Annual Current Liabilities
$27.45 M
+$3.08 M+12.62%
December 31, 2024
Summary
- As of March 12, 2025, KROS annual total current liabilities is $27.45 million, with the most recent change of +$3.08 million (+12.62%) on December 31, 2024.
- During the last 3 years, KROS annual current liabilities has risen by +$15.60 million (+131.72%).
- KROS annual current liabilities is now at all-time high.
Performance
KROS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$27.45 M
-$1.56 M-5.37%
December 31, 2024
Summary
- As of March 12, 2025, KROS quarterly total current liabilities is $27.45 million, with the most recent change of -$1.56 million (-5.37%) on December 31, 2024.
- Over the past year, KROS quarterly current liabilities has stayed the same.
- KROS quarterly current liabilities is now -5.37% below its all-time high of $29.01 million, reached on September 30, 2024.
Performance
KROS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
KROS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.6% | 0.0% |
| 3 y3 years | +131.7% | +131.7% |
| 5 y5 years | +511.9% | +511.9% |
KROS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +131.7% | -5.4% | +138.2% |
| 5 y | 5-year | at high | +511.9% | -5.4% | +511.9% |
| alltime | all time | at high | +511.9% | -5.4% | +511.9% |
Keros Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $27.45 M(+12.6%) | $27.45 M(-5.4%) |
| Sep 2024 | - | $29.01 M(+36.5%) |
| Jun 2024 | - | $21.25 M(+13.5%) |
| Mar 2024 | - | $18.72 M(-23.2%) |
| Dec 2023 | $24.37 M(+47.3%) | $24.37 M(+45.9%) |
| Sep 2023 | - | $16.70 M(+3.8%) |
| Jun 2023 | - | $16.09 M(+4.1%) |
| Mar 2023 | - | $15.46 M(-6.6%) |
| Dec 2022 | $16.55 M | $16.55 M(+43.6%) |
| Sep 2022 | - | $11.53 M(-25.4%) |
| Jun 2022 | - | $15.45 M(+32.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $11.65 M(-1.7%) |
| Dec 2021 | $11.85 M(+64.9%) | $11.85 M(+7.5%) |
| Sep 2021 | - | $11.02 M(+46.3%) |
| Jun 2021 | - | $7.53 M(-15.9%) |
| Mar 2021 | - | $8.95 M(+24.6%) |
| Dec 2020 | $7.18 M(+60.1%) | $7.18 M(+5.3%) |
| Sep 2020 | - | $6.83 M(-17.7%) |
| Jun 2020 | - | $8.29 M(-6.1%) |
| Mar 2020 | - | $8.84 M(+97.0%) |
| Dec 2019 | $4.49 M(-60.9%) | $4.49 M |
| Dec 2018 | $11.47 M | - |
FAQ
- What is Keros Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Keros Therapeutics?
- What is Keros Therapeutics annual current liabilities year-on-year change?
- What is Keros Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Keros Therapeutics?
- What is Keros Therapeutics quarterly current liabilities year-on-year change?
What is Keros Therapeutics annual total current liabilities?
The current annual current liabilities of KROS is $27.45 M
What is the all time high annual current liabilities for Keros Therapeutics?
Keros Therapeutics all-time high annual total current liabilities is $27.45 M
What is Keros Therapeutics annual current liabilities year-on-year change?
Over the past year, KROS annual total current liabilities has changed by +$3.08 M (+12.62%)
What is Keros Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of KROS is $27.45 M
What is the all time high quarterly current liabilities for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total current liabilities is $29.01 M
What is Keros Therapeutics quarterly current liabilities year-on-year change?
Over the past year, KROS quarterly total current liabilities has changed by $0.00 (0.00%)